Luan C. Martins
6627, Antônio Carlos Avenue
Belo Horizonte, MG 31270901, Brazil
Belo Horizonte, MG 31270901, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
5,6,7,8-Tetrahydroimidazo[1,2-a]pyrazine-based thiosemicarbazones as anti-Trypanosoma cruzi agents.
Journal: Bioorganic & medicinal chemistry
Published: January 24, 2026
Experimental and Computational Study of Aryl-thiosemicarbazones Inhibiting Cruzain Reveals Reversible Inhibition and a Stepwise Mechanism.
Journal: Journal of chemical information and modeling
Published: February 21, 2023
Screening the Pathogen Box to Discover and Characterize New Cruzain and TbrCatL Inhibitors.
Journal: Pathogens (Basel, Switzerland)
Published: December 22, 2022
Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity.
Journal: Nature
Published: August 19, 2021
Conformational dynamics of Tetracenomycin aromatase/cyclase regulate polyketide binding and enzyme aggregation propensity.
Journal: Biochimica et biophysica acta. General subjects
Published: March 31, 2021
Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking.
Journal: bioRxiv : the preprint server for biology
Published: December 03, 2020
Synthesis of quinoline derivatives as potential cysteine protease inhibitors.
Journal: Future medicinal chemistry
Published: March 03, 2020
Benzimidazole inhibitors of the major cysteine protease of Trypanosoma brucei.
Journal: Future medicinal chemistry
Published: August 31, 2019
Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'.
Journal: European journal of medicinal chemistry
Published: May 06, 2019
Investigation of the binding mode of a novel cruzain inhibitor by docking, molecular dynamics, ab initio and MM/PBSA calculations.
Journal: Journal of computer-aided molecular design
Published: September 22, 2017
Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification.
Journal: Bioorganic & medicinal chemistry
Published: January 09, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026